GIKLY
Price
$7.14
Change
-$0.35 (-4.67%)
Updated
Sep 4 closing price
Capitalization
8.55B
41 days until earnings call
ORINY
Price
$37.15
Change
-$1.91 (-4.89%)
Updated
Sep 25 closing price
Capitalization
10.84B
Interact to see
Advertisement

GIKLY vs ORINY

Header iconGIKLY vs ORINY Comparison
Open Charts GIKLY vs ORINYBanner chart's image
Grifols Sa
Price$7.14
Change-$0.35 (-4.67%)
Volume$171
Capitalization8.55B
Orion Corporation OY
Price$37.15
Change-$1.91 (-4.89%)
Volume$304
Capitalization10.84B
GIKLY vs ORINY Comparison Chart in %
Loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORINY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIKLY vs. ORINY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIKLY is a Buy and ORINY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (GIKLY: $7.14 vs. ORINY: $37.15)
Brand notoriety: GIKLY and ORINY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIKLY: 137% vs. ORINY: 44%
Market capitalization -- GIKLY: $8.55B vs. ORINY: $10.84B
GIKLY [@Pharmaceuticals: Major] is valued at $8.55B. ORINY’s [@Pharmaceuticals: Major] market capitalization is $10.84B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $640.6B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIKLY’s FA Score shows that 1 FA rating(s) are green whileORINY’s FA Score has 3 green FA rating(s).

  • GIKLY’s FA Score: 1 green, 4 red.
  • ORINY’s FA Score: 3 green, 2 red.
According to our system of comparison, ORINY is a better buy in the long-term than GIKLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIKLY’s TA Score shows that 4 TA indicator(s) are bullish while ORINY’s TA Score has 3 bullish TA indicator(s).

  • GIKLY’s TA Score: 4 bullish, 3 bearish.
  • ORINY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GIKLY is a better buy in the short-term than ORINY.

Price Growth

GIKLY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while ORINY (@Pharmaceuticals: Major) price change was -4.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.07%. For the same industry, the average monthly price growth was -0.30%, and the average quarterly price growth was +12.81%.

Reported Earning Dates

GIKLY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.07% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORINY($10.8B) has a higher market cap than GIKLY($8.55B). GIKLY has higher P/E ratio than ORINY: GIKLY (27.47) vs ORINY (23.38). ORINY YTD gains are higher at: 71.811 vs. GIKLY (53.720). GIKLY has higher annual earnings (EBITDA): 1.62B vs. ORINY (481M). GIKLY has more cash in the bank: 566M vs. ORINY (184M). ORINY has less debt than GIKLY: ORINY (318M) vs GIKLY (8.82B). GIKLY has higher revenues than ORINY: GIKLY (7.45B) vs ORINY (1.68B).
GIKLYORINYGIKLY / ORINY
Capitalization8.55B10.8B79%
EBITDA1.62B481M336%
Gain YTD53.72071.81175%
P/E Ratio27.4723.38118%
Revenue7.45B1.68B444%
Total Cash566M184M308%
Total Debt8.82B318M2,773%
FUNDAMENTALS RATINGS
GIKLY vs ORINY: Fundamental Ratings
GIKLY
ORINY
OUTLOOK RATING
1..100
3225
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
10024
SMR RATING
1..100
8421
PRICE GROWTH RATING
1..100
4546
P/E GROWTH RATING
1..100
8173
SEASONALITY SCORE
1..100
7538

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORINY's Valuation (24) in the null industry is in the same range as GIKLY (28). This means that ORINY’s stock grew similarly to GIKLY’s over the last 12 months.

ORINY's Profit vs Risk Rating (24) in the null industry is significantly better than the same rating for GIKLY (100). This means that ORINY’s stock grew significantly faster than GIKLY’s over the last 12 months.

ORINY's SMR Rating (21) in the null industry is somewhat better than the same rating for GIKLY (84). This means that ORINY’s stock grew somewhat faster than GIKLY’s over the last 12 months.

GIKLY's Price Growth Rating (45) in the null industry is in the same range as ORINY (46). This means that GIKLY’s stock grew similarly to ORINY’s over the last 12 months.

ORINY's P/E Growth Rating (73) in the null industry is in the same range as GIKLY (81). This means that ORINY’s stock grew similarly to GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIKLYORINY
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
45%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
36%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
34%
Advances
ODDS (%)
N/A
Bullish Trend 23 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 30 days ago
36%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORINY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CORN17.72N/A
N/A
Teucrium Corn Fund
FRI27.64-0.07
-0.26%
First Trust S&P REIT ETF
CBOA26.57-0.09
-0.32%
Calamos Bitcoin Structured Alt Protection ETF - April
FEMB29.22-0.22
-0.74%
First Trust Emerging Mkts Lcl Ccy Bd ETF
EQTY25.43-0.30
-1.18%
Kovitz Core Equity ETF

GIKLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIKLY has been closely correlated with GRFS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIKLY jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
N/A
GRFS - GIKLY
68%
Closely correlated
-1.01%
GIFOF - GIKLY
27%
Poorly correlated
N/A
GIFLF - GIKLY
25%
Poorly correlated
N/A
ORINY - GIKLY
9%
Poorly correlated
-4.89%
OPHLY - GIKLY
8%
Poorly correlated
-1.58%
More

ORINY and

Correlation & Price change

A.I.dvisor tells us that ORINY and GIKLY have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORINY and GIKLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORINY
1D Price
Change %
ORINY100%
-4.89%
GIKLY - ORINY
9%
Poorly correlated
N/A
GLAXF - ORINY
6%
Poorly correlated
+2.75%
NVSEF - ORINY
5%
Poorly correlated
N/A
OPHLY - ORINY
3%
Poorly correlated
-1.58%
MAYNF - ORINY
0%
Poorly correlated
N/A
More